Physician profile
Eric D Forney
NPI 1841721826
$2,400.89
in general payments reported to CMS, 2019-2025
26 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $515 · 2021: $310 · 2022: $60.89 · 2023: $260 · 2024: $864 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $967 · Travel and Lodging: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $967.09 |
| Travel and Lodging | $356.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $754.64 | 2023-2025 | |
| Acell, INC. | $289.86 | 2020 | |
| Kerecis Limited | $166.49 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Depuy Synthes Sales INC. | $134.08 | 2020-2024 | Trumatch |
| Avanos Medical | $128.38 | 2019-2021 | |
| Avita Medical Americas, LLC | $110.67 | 2024-2025 | Permeaderm, Recell, Cohealyx |
| Allergan, INC. | $99.70 | 2019-2021 | |
| Stryker Corporation | $95.53 | 2023-2024 | Na, Vsp System, Vsp Cranial, Stryker |
| Baxter Healthcare | $81.43 | 2019-2021 | |
| Portola Pharmaceuticals, LLC | $65.98 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $63.53 | 2019-2021 | |
| Axogen | $49.28 | 2025 | |
| Gotham Surgical Solutions & Devices, INC. | $46.50 | 2022 | |
| Polarityte, INC. | $42.23 | 2021 | |
| Pfizer INC. | $38.77 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $34.17 | 2020-2021 | |
| Intuitive Surgical, INC. | $27.86 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $26.79 | 2021 | |
| Davol INC. | $24.95 | 2025 | Phasix Mesh |
| Musculoskeletal Transplant Foundation INC. | $21.87 | 2023 | |
| Ambu INC. | $19.47 | 2023 | |
| Chiesi USA, INC. | $18.98 | 2020 | |
| Integra Lifesciences Corporation | $17.31 | 2019 | |
| Shire North American Group INC | $17.01 | 2019 | |
| Heron Therapeutics, INC. | $14.03 | 2021 | |
| Ethicon US, LLC | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Forney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.